[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

<p>Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.</p><p><a href="https://www.caixinglobal.com/2023-06-02/brand-name-drugs-feel-the-squeeze-in-chinas-generic-heavy-market-102061416.html" rel="noopener noreferrer" target="_blank">Click here to read the article by Tang Hanyu&nbsp;and&nbsp;Kelly Wang.</a></p><p>Narrated by Elyse Ribbons.</p><p>See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.</p>